Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation Journal Article


Authors: Avery, S.; Voss, M. H.; Gonzales, A. M.; Lubin, M.; Castro-Malaspina, H.; Giralt, S.; Kernan, N. A.; Scaradavou, A.; Hedvat, C. V.; Stevens, C. E.; Barker, J. N.
Article Title: Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation
Abstract: Delayed or failed engraftment remains a concern after cord blood transplantation (CBT) even when using double-unit grafts. Therefore, we analyzed the association between BM assessment performed approximately 21 days after transplantation, and the speed and success of sustained donor-derived neutrophil engraftment in 56 myeloablative double-unit CBT (DCBT) recipients. Overall, the cumulative incidence of sustained neutrophil engraftment was 95% (95% confidence intervals (CI): 89-100). Of the percentage of myeloid precursors, the BM cellularity and the total donor chimerism the total donor chimerism percentage had the most critical association with the speed and success of engraftment. DCBT recipients who were 100% donor achieved a 98% engraftment rate at a median of 22 days. This compared with 100% engraftment in patients who were 90-99% donor, but at a delayed median of 29 days and only 68% engraftment in patients 90% donor at a median of 37 days (P0.001). Multivariate analysis was performed in the subgroup of patients who had not engrafted at the time the BM analysis was performed, the subgroup of most clinical concern. This confirmed donor chimerism was predictive of subsequent neutrophil recovery (P0.004). These findings demonstrate the importance of the day 21 BM chimerism determinations after DCBT. © 2012 Macmillan Publishers Limited.
Keywords: adolescent; adult; child; preschool child; child, preschool; middle aged; transplantation, homologous; major clinical study; bone marrow cells; time factors; acute leukemia; cord blood stem cell transplantation; engraftment; graft failure; hematologic neoplasms; bone marrow biopsy; lymphoma; cell count; neutrophils; clinical effectiveness; graft survival; donor selection; myeloid progenitor cell; graft recipient; transplantation chimera; bone marrow examination; histocompatibility; cord blood transplantation; chimerism; cellular parameters; bone marrow cellularity; double unit cord blood stem cell transplantation; neutrophil engraftment; neutrophil recovery
Journal Title: Bone Marrow Transplantation
Volume: 47
Issue: 8
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2012-08-01
Start Page: 1056
End Page: 1060
Language: English
DOI: 10.1038/bmt.2011.236
PROVIDER: scopus
PUBMED: 22139066
PMCID: PMC3970438
DOI/URL:
Notes: --- - "Export Date: 4 September 2012" - "CODEN: BMTRE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Kernan
    512 Kernan
  2. Cyrus Hedvat
    126 Hedvat
  3. Sergio Andres Giralt
    1050 Giralt
  4. Martin Henner Voss
    288 Voss
  5. Juliet N Barker
    335 Barker
  6. Sharon Avery
    6 Avery
  7. Marissa N Lubin
    79 Lubin
  8. Cladd Stevens
    17 Stevens